Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody.
Bispecific antibodies
Correct pairing of cognate heavy chains
Disulfide bond mapping
Engineered cysteines
Heterodimerization of heavy chains
Knob-into-hole (KiH)
Mispair
light chains
Journal
Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
16
02
2021
revised:
15
04
2021
accepted:
15
04
2021
pubmed:
25
4
2021
medline:
5
8
2021
entrez:
24
4
2021
Statut:
ppublish
Résumé
Site-specific cysteine engineering, along with other genetic mutations, is broadly implemented in bispecific antibodies (bsAb). Thus far, homodimer, half hole antibody, one-light chain mispaired and light chain swapped variants have been reported as chain-pairing variants for the asymmetric IgG-like bispecific antibodies. Here we report a novel mispair in which the C
Identifiants
pubmed: 33894207
pii: S0022-3549(21)00232-X
doi: 10.1016/j.xphs.2021.04.010
pii:
doi:
Substances chimiques
Antibodies, Bispecific
0
Immunoglobulin G
0
Cysteine
K848JZ4886
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2904-2915Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.